Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin. 3-Nitropropionic acid

Annals of Neurology

Volumn 45, Issue 5, 1999, Pages 640-651

  Nakao, Naoyuki ^a   Nakai, Ekini ^a   Nakai, Kunio ^a   Itakura, Toru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; FLUOROGOLD; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; CELL ACTIVITY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; MALE; MORPHOLOGY; NERVE ENDING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

ANIMALS; CATHETER ABLATION; CELL SURVIVAL; DOPAMINE; MALE; NEURONS; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; THALAMIC NUCLEI;

EID: 0032964444     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199905)45:5<640::AID-ANA13>3.0.CO;2-U     Document Type: Article

References (44)

1. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366
2. Novelli A, Reilly JA, Lysko PG, et al. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451:205-212
3. Zeevalk GD, Nicklas WJ. Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J Pharmacol Exp Ther 1990;253:1285-1292
4. Zeevalk GD, Nicklas WJ. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J Pharmacol Exp Ther 1991;257:870-878
5. Nakao N, Nakai K, Itakura T. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro. Brain Res 1997;777:202-209
6. +) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon. J Neurosci Res 1996;43:55-62
7. Zeevalk GD, Derr-Yellin E, Nicklas WJ. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J Neurochem 1995;64:455-458
8. Zeevalk GD, Derr-Yellin E, Nicklas WJ. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J Pharmacol Exp Ther 1995;275:1124-1130
9. Marey-Semper I, Gelman M, Lévi-Strauss M. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by synergistic effects of energetic metabolism impairment and NMDA receptor activation. J Neurosci 1995;15:5912-5918
10. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 1991;349:414-418
11. Zuddas A, Oberto G, Vaglini F, et al. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. J Neurochem 1992;52:733-739
12. Kupsch A, Burg M, Wachtel H, et al. Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunohistochemical analyses in black mice. Brain Res 1992; 592:74-83
13. Sonsalla PK, Zeevalk GD, Manzino L, et al. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J Neurochem 1992;58:1979-1982
14. Charara A, Smith Y, Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 1996;364:254-266
15. Gonzales C, Chesselet M-F. Amygdalonigral pathway: an anterograde study in the rat with Phaseolus vulgaris-leucoagglutinin (PHA-L). J Comp Neurol 1990;297:182-200
16. Kornhuber J, Kim J-S, Kornhuber ME, et al. The cortico-nigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res 1984; 322:124-126
17. Naito A, Kita H. The cortico-nigral projection in the rat: an anterograde tracing study with biotinylated dextran amine. Brain Res 1994;637:317-322
18. Smith Y, Hazarati L-N, Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol 1990;294: 306-323
19. Nakao N, Ogura M, Nakai K, et al. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease. J Neurosci 1998;18:1806-1817
20. Vila M, Levy R, Herrero M-T, et al. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and nonhuman primates: a cytochrome oxidase histochemistry. Neuroscience 1996;71:903-912
21. Vila M, Levy R, Herrero M-T, et al. Consequences of nigrostriatal denervation on the function of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 1997;71:903-912
22. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121:451-457
23. Limousin P, Pollack P, Benazzouz A, et al. Effect on parkinsonian sign and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95
24. Coles CJ, Edmondson DE, Singer TP. Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 1979;254: 5161-5167
25. Nakao N, Brundin P. Effects of α-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 1997;76:749-761
26. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press, 1984
27. Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994;59:401-415
28. Nakao N, Odin P, Lindvall O, et al. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp Neurol 1995;138:144-157
29. Nakao N, Grasbon-Frodl EM, Widner H, et al. Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience 1996;73:185-200
30. Wong-Riley MMT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989;12: 94-101
31. Aronin N, Chase K, Sagar F, et al. NMDA receptor activation in the neostriatum increases cFOS and FOS related antigen selectively in medium sized neurons. Neuroscience 1991;44:409-420
32. MacDonald MC, Pollack P, Benazzouz A, et al. Effects on parkinsonian sign and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95
33. Sauer H, Rosenblad C, Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor b3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci USA 1995;92:8395-8939
34. Piallat B, Benazzouz A, Benabid AL. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci 1996;8:1408-1414
35. Beal MF, Brouillet E, Jenkins BG, et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181-4192
36. Brouillet E, Jenkins BG, Hyman BT, et al. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 1993;60:356-369
37. Paquet M, Tremblay M, Soghomonian JJ, et al. AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci 1997;17:1377-1396
38. Cox JA, Lysko PG, Henneberry RC. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: role of the voltage-dependent magnesium block. Brain Res 1989;499:267-272
39. Rodriguez MC, Obeso JA, Olanow CA. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 1988;44:175-188
40. Heikkila RE, Cohen G. 6-Hydroxydopamine: evidence for superoxide radical as an oxidant intermediate. Science 1973;181: 456-457
41. Charlety PJ, Grenhoff J, Chergui K, et al. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. Acta Physiol Scand 1991;142:105-112
42. Chergui K, Akaoka H, Charlety PJ, et al. Subthalamic nucleus modulates burst firing in nigral dopamine neurones via NMDA receptors. Neuroreport 1994;5:1185-1188
43. Smith ID, Grace AA. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 1992; 12:287-303
44. +) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Neurobiol Aging 1993;14:295-301